Jefferies Financial Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,000
Closed -$135K 1923
2025
Q3
$135K Hold
16,000
﹤0.01% 1316
2025
Q2
$180K Buy
+16,000
New +$147K ﹤0.01% 1137
2025
Q1
Sell
-210,100
Closed -$2.36M 1728
2024
Q4
$2.36M Sell
210,100
-76,300
-27% -$1.34M 0.01% 617
2024
Q3
$8.1M Buy
286,400
+17,000
+6% +$438K 0.06% 216
2024
Q2
$5.15M Buy
269,400
+228,600
+560% +$5.84M 0.05% 281
2024
Q1
$1.34M Sell
40,800
-5,000
-11% -$160K 0.01% 722
2023
Q4
$1.51M Sell
45,800
-8,000
-15% -$226K 0.01% 816
2023
Q3
$1.46M Sell
53,800
-1,700
-3% -$47.3K 0.01% 711
2023
Q2
$1.68M Sell
55,500
-10,000
-15% -$323K 0.02% 724
2023
Q1
$2.13M Hold
65,500
0.02% 642
2022
Q4
$1.84M Buy
+65,500
New +$1.88M 0.01% 688

Other funds holding EVH

Jefferies Financial Group's EVH Position: Q1 2026 in Review

Jefferies Financial Group held its Evolent Health (EVH) position steady in Q1 2026 at 291,600 shares worth $665K. The position accounts for ﹤0.01% of the portfolio, ranked #1085.

Jefferies Financial Group first reported a position in EVH in Q4 2022 and has held it in 14 quarters since. The position peaked at $5.4M in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Jefferies Financial Group held 291,600 shares of Evolent Health worth $665K as of Q1 2026.
  • Jefferies Financial Group left its Evolent Health share count unchanged in Q1 2026.
  • Evolent Health made up ﹤0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #1085 holding.
  • Jefferies Financial Group first reported a position in Evolent Health in Q4 2022 and has held it in 14 quarters since.
  • Jefferies Financial Group's Evolent Health position peaked at $5.4M in Q2 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.